
Limited time offer ⏰ Submit your work by 31st December 2026 and publish #OpenAccess for free! 🔓 Visit our website for more information 👇 sciencedirect.com/journal/th…


Limited time offer ⏰ Submit your work by 31st December 2026 and publish #OpenAccess for free! 🔓 Visit our website for more information 👇 sciencedirect.com/journal/th…

Human living myocardial slices as a new approach methodology 🫀 This review by Lorenza Koppers, Fani Koutentaki, and Cesare Terracciano discusses the history and potential of living myocardial slices. 🔗 Read the Open Access paper here: buff.ly/J7VXXlS

Just two weeks remaining to submit your Editorial Board member application!📣 JPM is looking to expand the journal's scientific reach and representation! To apply, please submit a statement of interest, CV and a short biography to jpm@physoc.org by 30 November 2026.

We have four Special Issues still welcoming submissions: 🔗 View them all here: buff.ly/Prlz0K3 Submit to JPM on or before 31 December for free Open Access publication

Artificial Intelligence Across the Drug Discovery Pipeline 💊 Read the recent review by Abhishek Kumar and colleagues published in JPM. 🔗 buff.ly/gFE8gNu

💊 In this review, Milad Alucozai and Colleen Clancy discuss the shift from traditional drug development pipelines towards platform-enabled evidence generation for increasingly personalised therapies. 👉️ Read the full article: buff.ly/YXo4SVs

📣 A reminder: we're looking for nominations for new Editorial Board members! 👉️ Submit a statement of interest, CV and a short biography to jpm@physoc.org by 30 November 2026.

📣 New Research! Sanne van Dijk and colleagues use a Bayesian multilevel modeling approach to quantify patient-level uncertainty in chronic disease dynamics 🧑⚕️ Read the full paper here: buff.ly/TjPpCSB

🏆 In case you missed it 🏆 The 2025 Best Paper Prize in JPM was awarded to the paper: 'Replicating clinical placebo effects in computational trials: Bridging the gap between in silico and clinical studies' 📄 Read the full paper here: buff.ly/rvckX7S

📢 Call for Papers📢 We invite submissions exploring how advances in ion channel biology are driving precision medicine across cardiovascular, neurological, oncological, metabolic and rare diseases. 🗓️ Submit by 31 December 2026 to claim free #OpenAccess publication!

📣 Repurposing GLP-1 receptor agonists for Alzheimer's disease 🧠💊 📄 In this review, Shreyas Adhikari et al. (Uni of Oxford), examine the evidence for the neuroprotective effects of GLP-1 RAs. 🔗 Link here: buff.ly/aNRF96Y

📣 Call for Editorial Board member nominations! 👨🔬 Self-nominations are warmly welcomed! 👉️ Submit a statement of interest, CV and a short biography to jpm@physoc.org by 30 November 2026.

📣 New review! 👇️ Mechanisms of apoptotic dysregulation in oncogenesis and targeted therapeutic interventions (Rani Joseph et al.) 🔗 Read the full paper: buff.ly/tNNBh9c

📢 Call for Papers 📢 Examining AI, digital twins, automation, high-throughput technologies, multi-omics integration and human-relevant disease models that are transforming precision medicine and translational research. 🗓️ Submit by 31 December 2026 for no #OpenAccess fees!

🫀🖥️ A computational fluid dynamics model of venous thrombogenesis 📄 Sunday George and Malebogo Ngoepe (University of Cape Town) investigate how valve aperture influences haemodynamics and clot formation. 🔗 Full paper: buff.ly/1nwj0OH

Submit on or before December 31st for free Open Access publication!🔓️ The Journal of Precision Medicine: Health and Disease is offering a full waiver for all authors who submit in 2026 ⏰ 🔗 Journal homepage: buff.ly/lZT8u3f